• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价住院患者药物不良事件预测风险模型。

Systematic review of predictive risk models for adverse drug events in hospitalized patients.

机构信息

School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, QLD, 4102, Australia.

Princess Alexandra Hospital, Metro South Health, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia.

出版信息

Br J Clin Pharmacol. 2018 May;84(5):846-864. doi: 10.1111/bcp.13514. Epub 2018 Feb 22.

DOI:10.1111/bcp.13514
PMID:29337387
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5903258/
Abstract

AIM

An emerging approach to reducing hospital adverse drug events is the use of predictive risk scores. The aim of this systematic review was to critically appraise models developed for predicting adverse drug event risk in inpatients.

METHODS

Embase, PubMed, CINAHL and Scopus databases were used to identify studies of predictive risk models for hospitalized adult inpatients. Studies had to have used multivariable logistic regression for model development, resulting in a score or rule with two or more variables, to predict the likelihood of inpatient adverse drug events. The Checklist for the critical Appraisal and data extraction for systematic Reviews of prediction Modelling Studies (CHARMS) was used to critically appraise eligible studies.

RESULTS

Eleven studies met the inclusion criteria and were included in the review. Ten described the development of a new model, whilst one study revalidated and updated an existing score. Studies used different definitions for outcome but were synonymous with or closely related to adverse drug events. Four studies undertook external validation, five internally validated and two studies did not validate their model. No studies evaluated impact of risk scores on patient outcomes.

CONCLUSION

Adverse drug event risk prediction is a complex endeavour but could help to improve patient safety and hospital resource management. Studies in this review had some limitations in their methods for model development, reporting and validation. Two studies, the BADRI and Trivalle's risk scores, used better model development and validation methods and reported reasonable performance, and so could be considered for further research.

摘要

目的

减少医院药物不良事件的一种新兴方法是使用预测风险评分。本系统评价的目的是批判性评估用于预测住院患者药物不良事件风险的模型。

方法

使用 Embase、PubMed、CINAHL 和 Scopus 数据库来确定针对住院成年患者的预测风险模型的研究。研究必须使用多变量逻辑回归来开发模型,从而得出具有两个或更多变量的评分或规则,以预测住院药物不良事件的可能性。使用预测模型研究的系统评价的批判性评估和数据提取清单(CHARMS)来批判性地评估合格的研究。

结果

有 11 项研究符合纳入标准并被纳入综述。其中 10 项描述了新模型的开发,而 1 项研究对现有评分进行了重新验证和更新。研究使用不同的结局定义,但与药物不良事件同义或密切相关。四项研究进行了外部验证,五项进行了内部验证,两项研究未验证其模型。没有研究评估风险评分对患者结局的影响。

结论

药物不良事件风险预测是一项复杂的工作,但可以帮助提高患者安全性和医院资源管理。本综述中的研究在模型开发、报告和验证方法方面存在一些局限性。有两项研究,即 BADRI 和 Trivalle 的风险评分,使用了更好的模型开发和验证方法,并报告了合理的性能,因此可以考虑进一步研究。

相似文献

1
Systematic review of predictive risk models for adverse drug events in hospitalized patients.系统评价住院患者药物不良事件预测风险模型。
Br J Clin Pharmacol. 2018 May;84(5):846-864. doi: 10.1111/bcp.13514. Epub 2018 Feb 22.
2
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.
3
Prognostic prediction models and clinical tools based on consensus to support patient prioritization for clinical pharmacy services in hospitals: A scoping review.基于共识的预后预测模型和临床工具,以支持医院临床药学服务中的患者优先排序:范围综述。
Res Social Adm Pharm. 2021 Apr;17(4):653-663. doi: 10.1016/j.sapharm.2020.08.002. Epub 2020 Aug 25.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Electronic health record-based prediction models for in-hospital adverse drug event diagnosis or prognosis: a systematic review.基于电子健康记录的院内药物不良事件诊断或预后预测模型:系统评价。
J Am Med Inform Assoc. 2023 Apr 19;30(5):978-988. doi: 10.1093/jamia/ocad014.
6
7
Evaluation of two European risk models for predicting medication harm in an Australian patient cohort.评估两个欧洲风险模型在澳大利亚患者队列中预测药物伤害的能力。
Eur J Clin Pharmacol. 2022 Apr;78(4):679-686. doi: 10.1007/s00228-021-03271-1. Epub 2022 Jan 18.
8
Development and validation of the Adverse Inpatient Medication Event model (AIME).不良住院药物事件模型(AIME)的开发与验证。
Br J Clin Pharmacol. 2021 Mar;87(3):1512-1524. doi: 10.1111/bcp.14560. Epub 2020 Nov 5.
9
Development and validation of a complexity score to rank hospitalized patients at risk for preventable adverse drug events.用于对有可预防药物不良事件风险的住院患者进行排名的复杂性评分的开发与验证。
Am J Health Syst Pharm. 2017 Dec 1;74(23):1970-1984. doi: 10.2146/ajhp160995.
10
A systematic review of the quality of clinical prediction models in in vitro fertilisation.体外受精中临床预测模型质量的系统评价。
Hum Reprod. 2020 Jan 1;35(1):100-116. doi: 10.1093/humrep/dez258.

引用本文的文献

1
Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary Hospital.评估风险类别在一家四级医院对患者进行优先级排序以实现最佳用药史完善的有效性。
Hosp Pharm. 2025 Aug 28:00185787251365525. doi: 10.1177/00185787251365525.
2
Development and validation of a risk prediction tool for drug-related problems in pre-operative elective surgical patients (mediPORT): A case-control study.术前择期手术患者药物相关问题风险预测工具(mediPORT)的开发与验证:一项病例对照研究。
PLoS One. 2025 Sep 2;20(9):e0326088. doi: 10.1371/journal.pone.0326088. eCollection 2025.
3
Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review.迈向电子健康记录中用于药物安全评估的处方监测系统:一项范围综述
BMC Med Inform Decis Mak. 2025 Jul 2;25(1):244. doi: 10.1186/s12911-025-03096-3.
4
Challenges in detecting and predicting adverse drug events via distributed analysis of electronic health record data from German university hospitals.通过对德国大学医院电子健康记录数据进行分布式分析来检测和预测药物不良事件所面临的挑战。
PLOS Digit Health. 2025 Jun 26;4(6):e0000892. doi: 10.1371/journal.pdig.0000892. eCollection 2025 Jun.
5
Evaluation of a score for identifying hospital stays that trigger a pharmacist intervention: integration into a clinical decision support system.用于识别引发药师干预的住院时间的评分评估:整合到临床决策支持系统中。
JAMIA Open. 2025 May 5;8(3):ooaf030. doi: 10.1093/jamiaopen/ooaf030. eCollection 2025 Jun.
6
Protocol for the development and validation of a Polypharmacy Assessment Score.多重用药评估分数的制定与验证方案。
Diagn Progn Res. 2024 Jul 16;8(1):10. doi: 10.1186/s41512-024-00171-7.
7
Patients' and Clinicians' Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews.患者和临床医生对化疗相关症状管理预测风险模型的临床实用性的看法:使用焦点小组和访谈进行定性探索。
J Med Internet Res. 2024 Jun 20;26:e49309. doi: 10.2196/49309.
8
Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma.用于评估戈利妥单抗治疗弥漫性大B细胞淋巴瘤时细胞因子释放综合征风险的预测模型。
Blood Adv. 2024 Jul 23;8(14):3615-3618. doi: 10.1182/bloodadvances.2023011089.
9
Healthcare risk stratification model for emergency departments based on drugs, income and comorbidities: the DICER-score.基于药物、收入和合并症的急诊科医疗风险分层模型:DICER 评分。
BMC Emerg Med. 2024 Feb 14;24(1):23. doi: 10.1186/s12873-024-00946-7.
10
Proceedings of the International Ambulatory Drug Safety Symposium: Munich, Germany, June 2023.《国际非住院药物安全研讨会会议记录:德国慕尼黑,2023年6月》
Drug Saf. 2024 Jan;47(1):103-111. doi: 10.1007/s40264-023-01362-9. Epub 2023 Nov 2.

本文引用的文献

1
Improving medication safety: Development and impact of a multivariate model-based strategy to target high-risk patients.提高用药安全性:基于多变量模型的高危患者靶向策略的开发与影响
PLoS One. 2017 Feb 13;12(2):e0171995. doi: 10.1371/journal.pone.0171995. eCollection 2017.
2
Predicting the Risk of Adverse Drug Reactions in Older Inpatients: External Validation of the GerontoNet ADR Risk Score Using the CRIME Cohort.预测老年住院患者药物不良反应风险:使用CRIME队列对GerontoNet药物不良反应风险评分进行外部验证
Drugs Aging. 2017 Feb;34(2):135-142. doi: 10.1007/s40266-016-0428-4.
3
Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool.老年患者因药物不良反应而住院——对预测工具的需求。
Clin Interv Aging. 2016 May 2;11:497-505. doi: 10.2147/CIA.S99097. eCollection 2016.
4
Prediction models for cardiovascular disease risk in the general population: systematic review.普通人群心血管疾病风险预测模型:系统评价
BMJ. 2016 May 16;353:i2416. doi: 10.1136/bmj.i2416.
5
Medical error-the third leading cause of death in the US.医疗差错——美国第三大死因。
BMJ. 2016 May 3;353:i2139. doi: 10.1136/bmj.i2139.
6
The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia.在澳大利亚急性护理的整个患者就医过程中,药物错误和药物不良反应的程度。
Int J Evid Based Healthc. 2016 Sep;14(3):113-22. doi: 10.1097/XEB.0000000000000075.
7
Evaluating Discrimination of Risk Prediction Models: The C Statistic.评估风险预测模型的判别力:C统计量
JAMA. 2015 Sep 8;314(10):1063-4. doi: 10.1001/jama.2015.11082.
8
Detection of Patients at High Risk of Medication Errors: Development and Validation of an Algorithm.药物错误高风险患者的检测:一种算法的开发与验证
Basic Clin Pharmacol Toxicol. 2016 Feb;118(2):143-9. doi: 10.1111/bcpt.12473. Epub 2015 Sep 22.
9
Development of an obstetrics triage tool for clinical pharmacists.临床药师产科分诊工具的开发。
J Clin Pharm Ther. 2015 Oct;40(5):539-544. doi: 10.1111/jcpt.12301. Epub 2015 Jun 25.
10
Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review.最常被发现是严重不良反应独立危险因素的药物数量:一项系统文献综述。
Br J Clin Pharmacol. 2015 Oct;80(4):808-17. doi: 10.1111/bcp.12600. Epub 2015 May 19.